| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Wei-Che Lin, Pei-Chin Chen, Yung-Cheng Huang, Nai-Wen Tsai, Hsiu-Ling Chen, Hung-Chen Wang, Tsu-Kung Lin, Kun-Hsien Chou, Meng-Hsiang Chen, Yi-Wen Chen, Cheng-Hsien L. Dopaminergic Therapy Modulates Cortical Perfusion in Parkinson Disease With and Without Dementia According to Arterial Spin Labeled Perfusion Magnetic Resonance Imaging. Medicine. vol 95. issue 5. 2016-06-14. PMID:26844450. |
dopaminergic therapy modulates cortical perfusion in parkinson disease with and without dementia according to arterial spin labeled perfusion magnetic resonance imaging. |
2016-06-14 |
2023-08-13 |
Not clear |
| Wei-Che Lin, Pei-Chin Chen, Yung-Cheng Huang, Nai-Wen Tsai, Hsiu-Ling Chen, Hung-Chen Wang, Tsu-Kung Lin, Kun-Hsien Chou, Meng-Hsiang Chen, Yi-Wen Chen, Cheng-Hsien L. Dopaminergic Therapy Modulates Cortical Perfusion in Parkinson Disease With and Without Dementia According to Arterial Spin Labeled Perfusion Magnetic Resonance Imaging. Medicine. vol 95. issue 5. 2016-06-14. PMID:26844450. |
the authors examined the cerebral perfusion differences among 17 parkinson disease (pd) patients, 17 pd with dementia (pdd) patients, and 17 healthy controls and used asl-mri to assess the effects of dopaminergic therapies on perfusion in the patients. |
2016-06-14 |
2023-08-13 |
Not clear |
| Kenji Takeyoshi, Masatake Kurita, Satoshi Nishino, Mika Teranishi, Yukio Numata, Tadahiro Sato, Yoshiro Okub. Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function. Neuropsychiatric disease and treatment. vol 12. 2016-04-04. PMID:27042075. |
yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function. |
2016-04-04 |
2023-08-13 |
human |
| T C Booth, M Nathan, A D Waldman, A-M Quigley, A H Schapira, J Buscomb. The role of functional dopamine-transporter SPECT imaging in parkinsonian syndromes, part 1. AJNR. American journal of neuroradiology. vol 36. issue 2. 2016-01-04. PMID:24904053. |
the common pathologic pathway of these diseases, collectively described as parkinsonian syndromes, such as parkinson disease, multiple system atrophy, progressive supranuclear palsy, corticobasal degeneration, and dementia with lewy bodies, is degeneration of the presynaptic dopaminergic pathways in the basal ganglia. |
2016-01-04 |
2023-08-13 |
Not clear |
| Marina Garriga, Marta Milà, Manzoor Mir, Raid Al-Baradie, Sonia Huertas, Cesar Castejon, Laura Casas, Dolors Badenes, Nuria Giménez, M Angels Font, Jose M Gonzalez, Maria Ysamat, Miguel Aguilar, Mark Slevin, Jerzy Krupinsk. (123)I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component. Frontiers in systems neuroscience. vol 9. 2015-07-20. PMID:26190980. |
we evaluated the utility of datscan for the early diagnosis of dementia in patients with and without a clinical vascular component, and the association between neuropsychological function, vascular component and dopaminergic function on datscan. |
2015-07-20 |
2023-08-13 |
Not clear |
| David S Goldstei. Dysautonomia in Parkinson disease. Comprehensive Physiology. vol 4. issue 2. 2014-12-01. PMID:24715569. |
loss of cardiac sns innervation occurs independently of the loss of striatal dopaminergic innervation underlying the motor signs of pd and is associated with other nonmotor manifestations, including anosmia, rem behavior disorder, orthostatic hypotension (oh), and dementia. |
2014-12-01 |
2023-08-13 |
Not clear |
| Hélène Hall, Stefanie Reyes, Natalie Landeck, Chris Bye, Giampiero Leanza, Kay Double, Lachlan Thompson, Glenda Halliday, Deniz Kiri. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. Brain : a journal of neurology. vol 137. issue Pt 9. 2014-11-06. PMID:25062696. |
in patients with pure lewy body parkinson's disease, previous post-mortem studies have shown that dopaminergic and cholinergic regulatory projection systems degenerate, but the exact pathways that may explain the development of dementia in patients with parkinson's disease remain unclear. |
2014-11-06 |
2023-08-13 |
human |
| Hélène Hall, Stefanie Reyes, Natalie Landeck, Chris Bye, Giampiero Leanza, Kay Double, Lachlan Thompson, Glenda Halliday, Deniz Kiri. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. Brain : a journal of neurology. vol 137. issue Pt 9. 2014-11-06. PMID:25062696. |
all patients with parkinson's disease exhibited a similar 80-85% loss of pigmented a9 dopaminergic neurons, whereas patients with parkinson's disease dementia presented an additional loss in the lateral part of a10 dopaminergic neurons as well as ch4 nucleus basalis neurons. |
2014-11-06 |
2023-08-13 |
human |
| Hélène Hall, Stefanie Reyes, Natalie Landeck, Chris Bye, Giampiero Leanza, Kay Double, Lachlan Thompson, Glenda Halliday, Deniz Kiri. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. Brain : a journal of neurology. vol 137. issue Pt 9. 2014-11-06. PMID:25062696. |
patients with parkinson's disease dementia were differentiated by a significant reduction in hippocampal cholinergic activity, by a significant loss of non-pigmented lateral a10 dopaminergic neurons and ch4 cholinergic neurons (30 and 55% cell loss, respectively, compared with neuronal preservation in control subjects), and by an increase in the severity of α-synuclein pathology in the basal forebrain and hippocampus. |
2014-11-06 |
2023-08-13 |
human |
| Hélène Hall, Stefanie Reyes, Natalie Landeck, Chris Bye, Giampiero Leanza, Kay Double, Lachlan Thompson, Glenda Halliday, Deniz Kiri. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. Brain : a journal of neurology. vol 137. issue Pt 9. 2014-11-06. PMID:25062696. |
overall, these results point to increasing α-synuclein deposition and hippocampal dysfunction in a setting of more widespread degeneration of cortical dopaminergic and cholinergic pathways as contributing to the dementia occurring in patients with pure parkinson's disease. |
2014-11-06 |
2023-08-13 |
human |
| Ryuji Sakakibar. [Cognitive adverse effects of anticholinergic medication for overactive bladder in PD/DLB]. Rinsho shinkeigaku = Clinical neurology. vol 53. issue 11. 2014-09-19. PMID:24292000. |
overactive bladder (oab) is a common autonomic disorder due mostly to lesions in the micturition-inhibiting area (d1 dopaminergic pathway in the basal ganglia) in parkinson's disease (pd) and dementia with lewy bodies (dlb). |
2014-09-19 |
2023-08-12 |
Not clear |
| David Devos, Caroline Moreau, David Maltête, Romain Lefaucheur, Alexandre Kreisler, Alexandre Eusebio, Gilles Defer, Thavarak Ouk, Jean-Philippe Azulay, Pierre Krystkowiak, Tatiana Witjas, Marie Delliaux, Alain Destée, Alain Duhamel, Régis Bordet, Luc Defebvre, Kathy Dujardi. Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial. Journal of neurology, neurosurgery, and psychiatry. vol 85. issue 6. 2014-06-20. PMID:24218528. |
even with optimal dopaminergic treatments, many patients with parkinson's disease (pd) are frequently incapacitated by apathy prior to the development of dementia. |
2014-06-20 |
2023-08-12 |
Not clear |
| Leigh Christopher, Connie Marras, Sarah Duff-Canning, Yuko Koshimori, Robert Chen, Isabelle Boileau, Barbara Segura, Oury Monchi, Anthony E Lang, Pablo Rusjan, Sylvain Houle, Antonio P Strafell. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment. Brain : a journal of neurology. vol 137. issue Pt 2. 2014-04-11. PMID:24334314. |
our aim was to investigate both striatal and cortical dopaminergic changes in patients with parkinson's disease with mild cognitive impairment, who represent a vulnerable group for the development of dementia. |
2014-04-11 |
2023-08-12 |
human |
| Marco Onofrj, Sara Varanese, Laura Bonanni, John-Paul Taylor, Angelo Antonini, Enza Maria Valente, Simona Petrucci, Fabrizio Stocchi, Astrid Thomas, Bernardo Perfett. Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies. Journal of neurology. vol 260. issue 7. 2014-02-19. PMID:23400498. |
to study prevalence, specific patterns and response to treatment of tremor in dementia with lewy bodies (dlb), in comparison with other tremulous disorders prevalence, qualitative and quantitative features of tremor were studied in an incident cohort of 67 dopaminergic treatment naive dlb, 111 parkinson's disease (pd) and 34 essential tremor (et) patients. |
2014-02-19 |
2023-08-12 |
Not clear |
| Martijn L T M Müller, Kirk A Frey, Myria Petrou, Vikas Kotagal, Robert A Koeppe, Roger L Albin, Nicolaas I Bohne. β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Movement disorders : official journal of the Movement Disorder Society. vol 28. issue 3. 2013-09-20. PMID:23239424. |
the aim was to perform a correlative pet study to examine the relationship between neocortical β-amyloid deposition ([(11)c]-pittsburgh compound b), nigrostriatal dopaminergic denervation ([(11)c]-dihydrotetrabenazine), and pigd feature severity in pd patients at risk for dementia. |
2013-09-20 |
2023-08-12 |
Not clear |
| In-Uk Song, Young-Do Kim, Hyun-Ji Cho, Sung-Woo Chung, Yong-An Chun. An FP-CIT PET comparison of the differences in dopaminergic neuronal loss between idiopathic Parkinson disease with dementia and without dementia. Alzheimer disease and associated disorders. vol 27. issue 1. 2013-08-12. PMID:22354157. |
an fp-cit pet comparison of the differences in dopaminergic neuronal loss between idiopathic parkinson disease with dementia and without dementia. |
2013-08-12 |
2023-08-12 |
Not clear |
| Steven Wishart, Graeme J A Macphe. Evaluation and management of the non-motor features of Parkinson's disease. Therapeutic advances in chronic disease. vol 2. issue 2. 2012-12-20. PMID:23251743. |
other nms such as dementia and severe depression may be unresponsive to dopaminergic treatment and may reflect perturbations in cholinergic, serotonergic or noradrenergic neurotransmitter function. |
2012-12-20 |
2023-08-12 |
Not clear |
| Michael K Scullin, Lynn Marie Trotti, Anthony G Wilson, Sophia A Greer, Donald L Bliwis. Nocturnal sleep enhances working memory training in Parkinson's disease but not Lewy body dementia. Brain : a journal of neurology. vol 135. issue Pt 9. 2012-12-05. PMID:22907117. |
we found that digit span backward performance improved following a nocturnal sleep interval in patients with parkinson's disease on dopaminergic medication, but not in those not taking dopaminergic medication and not in patients with dementia with lewy bodies. |
2012-12-05 |
2023-08-12 |
Not clear |
| Sean J Colloby, Shane McParland, John T O'Brien, Johannes Attem. Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. Brain : a journal of neurology. vol 135. issue Pt 9. 2012-12-05. PMID:22961551. |
neuropathological correlates of dopaminergic imaging in alzheimer's disease and lewy body dementias. |
2012-12-05 |
2023-08-12 |
human |
| Ben Yang, Lauren B Geary, Yong-Chao M. In ovo electroporation in chick midbrain for studying gene function in dopaminergic neuron development. Journal of visualized experiments : JoVE. issue 66. 2012-10-22. PMID:22895156. |
the dysfunction of ventral midbrain dopaminergic neurons is implicated in parkinson's disease, schizophrenia, depression, and dementia. |
2012-10-22 |
2023-08-12 |
human |